Clinical Characteristics and Outcome of Patients with EZH2- Mutant Myelodysplastic Syndromes

被引：0
|
作者：
Ball, Somedeb [1 ]
Aguirre, Luis E. E. [1 ]
Jain, Akriti G. [1 ]
Hussaini, Mohammad O. [2 ]
Al Ali, Najla [3 ]
Tinsley-Vance, Sara Marie [1 ]
Chan, Onyee [4 ]
Kuykendall, Andrew T. [1 ]
Sweet, Kendra [1 ]
Lancet, Jeffrey E. [1 ]
Sallman, David A. [5 ]
Padron, Eric [1 ]
Komrokji, Rami S. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Hematopathol & Lab Med, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[4] Dept Malignant Hematol, Tampa, FL USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-153465
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1531
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Myelodysplastic syndromes in adolescents: characteristics and clinical outcome
    Zecca, M.
    Noellke, P.
    Bergstrasser, E.
    de Moerloose, B.
    Hasle, H.
    Matthes-Martin, S.
    Sainati, L.
    Stary, J.
    Strahm, B.
    van den Heuvel-Eibrink, M.
    Wojcik, D.
    Niemeyer, C.
    Locatelli, F.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S57 - S57
  • [2] MYELODYSPLASTIC SYNDROMES IN ADOLESCENTS: CHARACTERISTICS AND CLINICAL OUTCOME
    Zecca, M.
    Noellke, P.
    Bergstraesser, E.
    De Moerloose, B.
    Hasle, H.
    Matthens-Martin, S.
    Sainati, L.
    Stary, J.
    Strahm, B.
    van den Heuvel-Eibrink, M. M.
    Wojcik, D.
    Niemeyer, C. M.
    Locatelli, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : S1 - S1
  • [3] Clinical characteristics and outcomes of EZH2-mutant myelodysplastic syndrome: A large single institution analysis of 1774 patients
    Ball, Somedeb
    Aguirre, Luis E.
    Jain, Akriti G.
    Al Ali, Najla
    Tinsley, Sara M.
    Chan, Onyee
    Kuykendall, Andrew T.
    Sweet, Kendra
    Lancet, Jeffrey E.
    Sallman, David A.
    Hussaini, Mohammad Omar
    Padron, Eric
    Komrokji, Rami S.
    LEUKEMIA RESEARCH, 2023, 124
  • [4] CHROMOSOME INVESTIGATIONS AND CLINICAL OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    KADAM, P
    DADABHOY, K
    BHISEY, A
    ATHALE, U
    NAIR, C
    NAIR, R
    ADVANI, S
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1995, 101 : 163 - 169
  • [5] Myelodysplastic Syndromes with Hypocellular Marrow: Clinical Characteristics and Evaluation of Outcome
    Santini, Valeria
    Gioia, Daniela Maria
    Masiera, Elisa
    Poloni, Antonella
    Ferrero, Dario
    Fragasso, Alberto
    Finelli, Carlo
    Salvi, Flavia
    Gaidano, Gianluca
    Oliva, Esther Natalie
    Catarini, Massimo
    Cametti, Gianni
    Bonferroni, Margherita
    Danise, Paolo
    Tassara, Rodolfo
    Allione, Bernardino
    Cilloni, Daniela
    Castelli, Andrea
    Centurioni, Riccardo
    Ciravegna, Giorgio
    Visani, Giuseppe
    Musto, Pellegrino
    Balleari, Enrico
    Boveri, Emanuela
    Ponzoni, Maurilio
    Gianelli, Umberto
    Della Porta, Matteo Giovanni
    BLOOD, 2018, 132
  • [6] Underexpression of EZH2 in Myelodysplastic Syndromes
    Wei, Yue
    Cabrero, Monica
    Jia, Yu
    Zheng, Hong
    Yang, Hui
    Fang, Zhihong
    Bohannan, Zach
    Garcia-Manero, Guillermo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S231 - S231
  • [7] Characteristics and Outcome Of Myelodysplastic Syndromes (MDS) Patients With Autoimmune Diseases
    Komrokji, Rami S.
    Kulasekararaj, Austin G.
    Al Ali, Najla H.
    Kordasti, Shahram Y.
    Bart-smith, Emily
    Benjamin, Craig
    Padron, Eric
    Zhang, Ling
    Lancet, Jeffrey E.
    List, Alan
    Mufti, Ghulam J.
    Epling-Burnette, Pearlie K.
    BLOOD, 2013, 122 (21)
  • [8] Combining gene variants with clinical characteristics improves outcome prediction in Chinese patients with myelodysplastic syndromes
    Yu, Yan
    Zhang, Tongtong
    Bao, Xiebing
    Wang, Qinrong
    Zhang, Ling
    Hong, Yang
    Zeng, Zhao
    Shen, Hongjie
    Wu, Depei
    Pan, Jinlan
    Liu, Hong
    Chen, Suning
    Sun, Aining
    LEUKEMIA & LYMPHOMA, 2020, 61 (04) : 919 - 926
  • [9] Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms
    J Rinke
    J P Müller
    M F Blaess
    A Chase
    M Meggendorfer
    V Schäfer
    N Winkelmann
    C Haferlach
    N C P Cross
    A Hochhaus
    T Ernst
    Leukemia, 2017, 31 : 1936 - 1943
  • [10] Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms
    Rinke, J.
    Mueller, J. P.
    Blaess, M. F.
    Chase, A.
    Meggendorfer, M.
    Schaefer, V.
    Winkelmann, N.
    Haferlach, C.
    Cross, N. C. P.
    Hochhaus, A.
    Ernst, T.
    LEUKEMIA, 2017, 31 (09) : 1936 - 1943
12345